All News

Xalkori improves survival in patients with ALK-positive lymphoma.

Goals and milestone recognitions may help children with cancer get through treatment a little easier.

Clinical trial results suggests that pathologic complete response after HER2-positive therapy equates to great survival.

Small Yet Significant Steps in Treating Triple-Negative Breast Cancer

Aromatase inhibitors may help prevent breast cancer.

When it comes to relieving joint pain from aromatase inhibitors, motion is lotion.

Gazyva may become a standard treatment for older, sicker patient with CLL.

Patients with multiple myeloma fare better with continuous Revlimid (lenalidomide).